High materiality7/10
TransMedics price target raised to 80 from 75 at Stifel
Why it may matterVerify against the original reporting
Target upgrade; bullish setup
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Stifel raises TransMedics (TMDX) price target to 80 from 75; current price around 73.22, indicating upside potential.
- Stifel raises TMDX PT to 80; price 73.22.
Key facts
- 01
Target: $80
- 02
Posted price: $73.22
- 03
Analyst firm: Stifel Nicolaus
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.